The potent anthelmintic activity exhibited by the milbemycins continues to spur research to find new natural product and new semi-synthetic milbemycins with improved properties1 '2) .
We have previously reported the isolation and structure elucidation of the milbemycins VM44857, VM44864, VM44865 and VM44866(see Scheme 1) from a novel Streptomyces sp. designated E225. 3'4) In view of the potent in vitro and in vivo anthelmintic activity of two of these compounds3)
we investigated the fermentation broths of this organism in more detail, and have isolated 10 further, novel metabolites (compounds (1) to (10), Schemes 1 to 3ft).
In this paper, we describe the fermentation, isolation and structure elucidation studies on these metabolites, two of which possess new structural features for milbemycins. In addition, we describe NMRchemical shift trends in this series of compounds which may be useful in the structure elucidation of further metabolites.
Results and Discussion

Producing Strain
The metabolites were produced by fermentation of Streptomyces sp. E225 (NCIB 12310) or its morphological variant referred to as E225B (NCIB 12509)3). Both MAR. 1996 strains were maintained as vegetative mycelium in liquid nitrogen.
Fermentation More than one fermentation was used for the production of the metabolites, and for minor metabolites A (i) The first stage seed medium consisted of (all concentrations in g or ml/liter): Special peptone (Oxoid) 2.5, beef extract (Oxoid Lab. Lemco) 2.5, Tryptone (Oxoid) 2.5, neutralised soya peptone (Oxoid) 2.5, soluble starch (BDH) 2.5, malt extract (Oxoid) 2.5, glucose monohydrate 2.5, glycerol 2.5 and trace elements solution 10. Thetrace elements solution was as previously described4* except that the concentration ofCoCl2 à"6H2O was 0.5 g/liter. The pH of this solution was unadjusted. One flask of sterilized, first stage seed medium (100ml in 500 ml Erlenmeyer) was inoculated with one ampoule (1) to (10).
Compound Molecular formula Molecular weight [a]£5 + 108°(c 0.29 acetone). 
VM44867 (Process B, 100 liter).
The mycelial mass was extracted with acetone (2x40 liter) and then concentrated by removing the acetone. The residue (14 liter) was then extracted with CH2C12(2 x 6 liter) and the combined extracts were dried over MgSO4 and evaporated to an oil (40g). The residue was chromatographed on silica gel and eluted sequentially with 0 to 60% diethyl ether in hexane. Fractions containing VM44867 (HPLC   detection40) were combined and evaporated to an oil MAR. 1996 (66 mg Throughout the isolation and purification process the metabolites were monitored by HPLCusing diode-array detection. Manyof them were initially identified by their distinctive UVspectra (Table 1) . a Not clearly observed. bAssignment uncertain between pairs labelled b. c C-27-OMe <5H= 3.533 ppm. dAssignment uncertain. Broad singlet OHresonance at <s)H=2.68ppm probably due to C-6-OH. f4/6 7_oh= 1-6Hz. g4/6 7_Oh= 1-4Hz. Table   2 . The structure elucidation of the new metabolites was greatly facilitated by the availability of spectral data for the four related compounds already isolated and characterized4* and relied mainly on MS (Table 2) , XH NMR (Table 3 ) and 13C NMR data (Table 4 ). This section focuses on the key points of the structure elucidation of the more unusual metabolites. VM48641 (4). FAB-MSindicated a molecular weight of 628. The 13C NMRspectrum ( (Table 3) was solved with the aid of 2D *H COSY-45and deuterium exchange experiments, and contained the resonances of 2 hydroxyl protons. Thus VM48641 (4) was formulated as C36H52O9 (CH2O more than VM448644), see Scheme 1). The pattern of proton-to-proton scalar coupling connectivities in the 2D COSYspectrum was very similar to that of VM44864. However, an extra CH3Ogroup was present, no signals were seen for a CH2-27 unit, and H-9 was found to have a long-range connectivity to an aAssignment uncertain between pairs labelled ai, where "i" is a number. bThe calculated chemical shifts for C-36, C-37, C-38 and C-39 are 43.4, 25.6, 22.4 and 22.4ppm respectively5). CSC C-27-OMe=55.3ppm. dThe resonances ofC-2, C-4, C-7, C-8 and C-14 were assigned by reference to those of milbemycin B36). sp3 CH proton resonating at (5H=5.54ppm (4/9?271 .7 Hz). This proton was directly connected to a carbon resonating at 102.3ppm (2D XH, 13C HETCORexperiment) and exhibited a long-range connectivity to C-6 in a COLOCexperiment. With the exceptions of C-2, C-5, C-6, C-9, C-ll and C-27, the 13C NMRchemical shifts of (4) were almost identical to those of VM44864 (mean difference=0.12+0.12ppm (V)), and it was concluded that VM48641 (4) was the C-27 methoxyl analogue of VM44864.4)The observation of mutual positive NOE's between H-2 and H-27 established that the stereochemistry at C-27 was a, that is S, assuming the natural R stereochemistry exists at C-2. (4) is the same as VM448644) at all centres, and that the solution conformations of VM48641 (4) are very similar to those of VM44857(Scheme 1)4). VM48642 (5) . FAB-MSindicated a molecular weight of 708; the highest of any milbemycin produced by strain E225. The 13C NMRspectrum (Table 4) contained 40 resonances including those of 5 CH3-C groups, 8 CH2 groups, 9 sp3 CH groups, 9 sp2 CH groups, 2 sp3 C atoms and 7 sp2 C atoms, indicating the presence of 49 non-exchangeableprotons. The complexand overlapped XHNMRspectrum (Table 3) C-40 and H-40 to C-37 and C-39. The following couplings were observed in this system: 3/38 39~1.8, 4/38 400 .9 and V39)40-1.7Hz. With the exceptions of C-l to C-5 and C-26, the 13C chemical shifts of VM48642 (5) (5) is the same as VM448664) at all centres, and that the solution conformations of VM48642 (5) are very similar to those of VM44857 (Scheme 1)4). The structures of all other eight metabolites were solved in a similar fashion, mainly on the basis of the NMRdata (see Schemes 1 to 3 and Tables 3 and 4 ). The structure elucidation ofVM44868 (7) should be described specifically.
It was difficult to establish fragments of structure in the "southern" part of the molecule, on the basis of consecutive proton-to-proton connectivities, Fig. 1 . Contour plot of an expansion of the 2D XH, 13C COLOCNMR spectrum of VM44868 (7) in CDC13/TMS in the region of the resonance of C-7. The corresponding ID *H and 13C NMRspectra are plotted on the left and on top. Note that the intensity of the H-6a resonance is reduced relative to that of H-6b due to an unresolved 4-bond stereospecific "W"coupling to the C-7-OH proton. because of a large number of "spectroscopically silent" quaternary carbons in the region of the cyclohexenone ring (C-4, C-5, C-7 and C-8). In this case the 2D 1H, 13C COLOC experiment was particularly valuable for establishing long-range proton-to-carbon connectivities. Fig. 1 shows a contour plot of an expansion of the COLOCspectrum of (7) in the region of the resonance of C-7. This carbon displayed all 8 possible two-bond and three-bond connectivities, vital for the structure elucidation of this difficult region of the molecule. Chemical shift trends in the XHand 13C NMRdata. Having assembled such a large volume of NMRdata (Tables 3 and 4, and Tables 2 and 3 The further ten metabolites isolated from strain E225 are of note for their wide range of structures and the possession of unusual structural features: the C-27a-OMe group in VM48641 (4) and the furan sidechain in VM48642 (5) in particular.
However, we note that compounds with C-27 hydroxylation have recently been reported as natural products and are known as metabolites of the milbemycins and avermectins1}. Finally, we also note that since the completion of our structure elucidation work, Pfizer have reported8) a metabolite named UK-77,021, which is identical to VM48130 (2).
Anthelmintic Activities
Anthelmintic activity was assessed in vitro against Haemonchuscontortus L3 larvae and in vivo in an adult Trichostrongylus colubriformis-gerbil model (at 1 mg/ kg) as previously described3*. Compounds (4), (5), (6), (8) and (10) were without significant activity in either test. Compounds (7) and (9) 
and VM48130 (2) were active at 1.6, 0.2 and 0.002/ig/ml respectively in vitro and all were >99%effective /« vivo at the 1 mg/kg dose.
Experimental
All the NMR experiments were conducted at circa 300K in 0.5cm3 CDC13/TMSsolution (10 to 120him). *H and 13C NMRspectra were acquired under the same conditions as previously4) except for VM48642for which some experiments had to be repeated with increased relaxation delays due to the unexpectedly long spin-lattice relaxation times of the protons in the furan ring. When the 2D 1H, 13C HETCORand ID 13C DEPT-135 experiments were repeated the relaxation delays were set to 2.5 and 1.8 second respectively, and the sequences were also retuned for 1JCtH values of 180 rather than the normal 140 Hz, to take account of the very large values of VC?H in the furan ring. The 2D 1H, 13C COLOC experiment was repeated with relaxation delays increased from 1.0 to 2.5 seconds. HR-EI-MS and FAB-MSdata were recorded on VGAnalytical ZAB-1F instrument using thioglycerol and a saturated solution of sodium acetate in 3-nitro-benzyl alcohol as the FAB matrices. UVspectra were obtained during HPLCanalysis with diode-array detection (Waters 990 PDAdetector). HPLC conditions were as shown in the footnote to Table 1. 
